Chronic Granulomatous Disease (CGD) is a rare, inherited immunodeficiency caused by mutations in one or more components of the NADPH oxidase complex. This defect compromises the ability of phagocytes ...
BOSTON--(BUSINESS WIRE)--Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo treatments capable of precisely and durably engineering the hematopoietic system ...
Ensoma Inc.’s lead program, EN-374, has been granted orphan drug and rare pediatric disease designations by the FDA for the treatment of X-linked chronic granulomatous disease. Ensoma anticipates ...
A healthy woman aged 27 years has a 20-year history of granuloma annulare. Topical and intralesional corticosteroids have provided some relief. Antinuclear antibody, erythrocyte sedimentation rate, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results